IRIS Accounts Production v24.1.0.578 05475953 Board of Directors 1.10.22 30.9.23 30.9.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh054759532022-09-30054759532023-09-30054759532022-10-012023-09-30054759532021-09-30054759532021-10-012022-09-30054759532022-09-3005475953ns15:EnglandWales2022-10-012023-09-3005475953ns14:PoundSterling2022-10-012023-09-3005475953ns10:Director12022-10-012023-09-3005475953ns10:PrivateLimitedCompanyLtd2022-10-012023-09-3005475953ns10:SmallEntities2022-10-012023-09-3005475953ns10:AuditExempt-NoAccountantsReport2022-10-012023-09-3005475953ns10:SmallCompaniesRegimeForDirectorsReport2022-10-012023-09-3005475953ns10:SmallCompaniesRegimeForAccounts2022-10-012023-09-3005475953ns10:FullAccounts2022-10-012023-09-3005475953ns10:Director22022-10-012023-09-3005475953ns10:Director32022-10-012023-09-3005475953ns10:Director42022-10-012023-09-3005475953ns10:CompanySecretary12022-10-012023-09-3005475953ns10:RegisteredOffice2022-10-012023-09-3005475953ns5:CurrentFinancialInstruments2023-09-3005475953ns5:CurrentFinancialInstruments2022-09-3005475953ns5:ShareCapital2023-09-3005475953ns5:ShareCapital2022-09-3005475953ns5:RetainedEarningsAccumulatedLosses2023-09-3005475953ns5:RetainedEarningsAccumulatedLosses2022-09-3005475953ns5:PlantMachinery2022-10-012023-09-3005475953ns5:PlantMachinery2022-09-3005475953ns5:PlantMachinery2023-09-3005475953ns5:CostValuation2022-09-3005475953ns5:UnlistedNon-exchangeTradedns5:CostValuation2022-09-3005475953ns5:AdditionsToInvestments2023-09-3005475953ns5:UnlistedNon-exchangeTradedns5:AdditionsToInvestments2023-09-3005475953ns5:CostValuation2023-09-3005475953ns5:UnlistedNon-exchangeTradedns5:CostValuation2023-09-3005475953ns5:UnlistedNon-exchangeTraded2023-09-3005475953ns5:UnlistedNon-exchangeTraded2022-09-3005475953ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-09-3005475953ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-09-30
REGISTERED NUMBER: 05475953 (England and Wales)















LANCASTER HOUSE CONSULTING & DIAGNOSTIC
& SURGICAL LIMITED

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2023






LANCASTER HOUSE CONSULTING & DIAGNOSTIC
& SURGICAL LIMITED (REGISTERED NUMBER: 05475953)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2023










Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


LANCASTER HOUSE CONSULTING & DIAGNOSTIC
& SURGICAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 SEPTEMBER 2023







DIRECTORS: R Sharma MBBS. MRCP
A Sharma
A Sharma
N Sharma MS FRCS FRCS(Urol)





SECRETARY: N Sharma MS FRCS FRCS(Urol)





REGISTERED OFFICE: The Exchange
5 Bank Street
Bury
BL9 0DN





REGISTERED NUMBER: 05475953 (England and Wales)





ACCOUNTANTS: DTE Business Advisers Limited
The Exchange
5 Bank Street
Bury
Lancashire
BL9 0DN

LANCASTER HOUSE CONSULTING & DIAGNOSTIC
& SURGICAL LIMITED (REGISTERED NUMBER: 05475953)

STATEMENT OF FINANCIAL POSITION
30 SEPTEMBER 2023

2023 2022
Notes £    £   
FIXED ASSETS
Property, plant and equipment 4 - -
Investments 5 10,507,000 9,007,000
10,507,000 9,007,000

CURRENT ASSETS
Debtors 6 1,039,393 209,142
Cash at bank 806,079 2,664,257
1,845,472 2,873,399
CREDITORS
Amounts falling due within one year 7 (248,456 ) (942,239 )
NET CURRENT ASSETS 1,597,016 1,931,160
TOTAL ASSETS LESS CURRENT
LIABILITIES

12,104,016

10,938,160

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 12,104,014 10,938,158
SHAREHOLDERS' FUNDS 12,104,016 10,938,160

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

LANCASTER HOUSE CONSULTING & DIAGNOSTIC
& SURGICAL LIMITED (REGISTERED NUMBER: 05475953)

STATEMENT OF FINANCIAL POSITION - continued
30 SEPTEMBER 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 16 February 2024 and were signed on its behalf by:





N Sharma MS FRCS FRCS(Urol) - Director


LANCASTER HOUSE CONSULTING & DIAGNOSTIC
& SURGICAL LIMITED (REGISTERED NUMBER: 05475953)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2023


1. STATUTORY INFORMATION

Lancaster House Consulting & Diagnostic & Surgical Limited is a private company, limited by shares, registered in England and Wales, registration number 05475953. The registered office is The Exchange, 5 Bank Street, Bury, BL9 0DN.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

The directors have considered all relevant business risks and believe that the company is well placed to manage all of these risks successfully, thus the going concern basis of accounting has been adopted in preparing these financial statements.

Preparation of consolidated financial statements
The financial statements contain information about Lancaster House Consulting & Diagnostic & Surgical Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements.

Significant judgements and estimates
In the application of the company's accounting policies, the directors are required to make estimates and judgements. The estimates are based on historical experience and other relevant factors. Actual results may differ from these estimates.

The estimates are continually evaluated. Revisions to accounting estimates are recognised in the period in which the estimate is revised.

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are outlined below.

Making judgement on the level of provision required for the impairment of investments.

Revenue
Revenue comprises the aggregate of the fair value of the sale of services provided, net of rebates and discounts. Service revenues are recognised as those services are provided to patients.

Property, plant and equipment
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost

The residual values, estimated useful lives and depreciation method of property, plant and equipment are reviewed, and adjusted as appropriate, at each statement of financial position date. The effects of any revision are recognised in the income statement when the change arises.

LANCASTER HOUSE CONSULTING & DIAGNOSTIC
& SURGICAL LIMITED (REGISTERED NUMBER: 05475953)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2023


2. ACCOUNTING POLICIES - continued

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Investments in subsidiary undertakings are recognised at cost less any permanent diminution in value.

Fixed asset investments
Fixed asset investments are recognised at cost less any permanent diminution in value.

Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties and loans to related parties.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the income statement.

Basic financial liabilities are initially measured at transaction price and subsequently measured at amortised cost.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the income statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs
The company operates an approved defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to the income statement in the period to which they relate.

Income from fixed asset investments
Income from fixed asset investments are recognised when they become receivable and is credited to the income statement in the period to which they relate.

Dividends
Equity dividends are recognised when they become legally payable and are no longer at the discretion of the company.

LANCASTER HOUSE CONSULTING & DIAGNOSTIC
& SURGICAL LIMITED (REGISTERED NUMBER: 05475953)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2023


3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 19 (2022 - 24 ) .

4. PROPERTY, PLANT AND EQUIPMENT
Plant and
machinery
etc
£   
COST
At 1 October 2022
and 30 September 2023 262,054
DEPRECIATION
At 1 October 2022
and 30 September 2023 262,054
NET BOOK VALUE
At 30 September 2023 -

5. FIXED ASSET INVESTMENTS
Shares in
group Unlisted
undertakings investments Totals
£    £    £   
COST OR VALUATION
At 1 October 2022 4,000,000 5,007,000 9,007,000
Additions 1,500,000 - 1,500,000
At 30 September 2023 5,500,000 5,007,000 10,507,000
NET BOOK VALUE
At 30 September 2023 5,500,000 5,007,000 10,507,000
At 30 September 2022 4,000,000 5,007,000 9,007,000

Cost or valuation at 30 September 2023 is represented by:

Shares in
group Unlisted
undertakings investments Totals
£    £    £   
Cost 5,500,000 5,007,000 10,507,000

LANCASTER HOUSE CONSULTING & DIAGNOSTIC
& SURGICAL LIMITED (REGISTERED NUMBER: 05475953)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2023


6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 644,379 20,334
Other debtors 395,014 188,808
1,039,393 209,142

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors - 662,000
Taxation and social security 238,892 272,989
Other creditors 9,564 7,250
248,456 942,239